Detalhe da pesquisa
1.
Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis.
Hepatobiliary Pancreat Dis Int
; 22(3): 263-269, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36435702
2.
Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation.
Hepatobiliary Pancreat Dis Int
; 19(5): 449-454, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171652
3.
Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation.
Hepatobiliary Pancreat Dis Int
; 18(2): 158-163, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30692043
4.
Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 17(3): 227-232, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29709351
5.
Effective targeting of colorectal cancer cells using TORC1/2 kinase inhibitors in vitro and in vivo.
Future Oncol
; 12(4): 515-24, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26776341
6.
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 14(4): 361-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256079
7.
[Down-regulated clusterin expression enhances sensitivity of hepatoma cells to anti-cancer drugs].
Zhonghua Gan Zang Bing Za Zhi
; 23(11): 844-8, 2015 Nov.
Artigo
em Chinês
| MEDLINE | ID: mdl-26743245
8.
Food for thought on hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 18(5): 493-494, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047806
9.
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 12(2): 171-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23558072
10.
[Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis].
Zhonghua Yi Xue Za Zhi
; 93(12): 892-6, 2013 Mar 26.
Artigo
em Chinês
| MEDLINE | ID: mdl-23863671
11.
[Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines].
Zhonghua Gan Zang Bing Za Zhi
; 21(5): 376-80, 2013 May.
Artigo
em Chinês
| MEDLINE | ID: mdl-24025141
12.
[Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].
Zhonghua Gan Zang Bing Za Zhi
; 21(6): 452-8, 2013 Jun.
Artigo
em Chinês
| MEDLINE | ID: mdl-24034848
13.
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.
World J Gastroenterol
; 29(12): 1765-1778, 2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37032731
14.
[Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 20(8): 593-7, 2012 Aug.
Artigo
em Chinês
| MEDLINE | ID: mdl-23207153
15.
Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.
World J Clin Cases
; 10(11): 3321-3333, 2022 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35611205
16.
Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells.
World J Clin Cases
; 10(28): 10017-10030, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36246809
17.
Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 10(3): 289-94, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21669573
18.
[Expression features of glypican-3 and its diagnostic and differential values in hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 19(4): 260-5, 2011 Apr.
Artigo
em Chinês
| MEDLINE | ID: mdl-21586223
19.
[Inhibitory effect of miRNA silencing hypoxia-inducible factor alpha subunit gene on the proliferation of HepG2 cells].
Zhonghua Gan Zang Bing Za Zhi
; 19(4): 281-5, 2011 Apr.
Artigo
em Chinês
| MEDLINE | ID: mdl-21586227
20.
Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth.
World J Gastroenterol
; 27(23): 3327-3341, 2021 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34163115